Insulin-Like Growth Factor-1 Receptor Targeted Fluorescent Imaging for Gallbladder Cancer in Orthotopic Mouse Models
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Gallbladder cancer is fatal, but fluorescent imaging technology can facilitate timely diagnosis and improve patient outcomes. Fluorophore-conjugated insulin-like growth factor- 1 receptor (IGF-1R) targeted antibodies were used to visualize gallbladder cancer in orthotopic tumor mouse models. Methods: Western blotting, flow cytometric analysis, and confocal microscopy detected the expression of IGF-1R in SNU-308, SNU-478, and SNU-1196 bile duct cancer cells. In vivo imaging of SNU-478 and SNU-1196 subcutaneous tumors and orthotopic gallbladder tumor models of SNU-478 were performed after injection with DyLight 650-conjugated IGF-1R antibody. Results: Western blotting and flow cytometric analysis showed that IGF-1R was expressed in bile duct cancer cells, and confocal microscopy demonstrated that IGF-1R antibody was able to bind to IGF-1R on the cell membrane. Fluorescent IGF-1R antibody injected into the mouse tail vein made subcutaneous tumors and orthotopic tumors become fluorescent. The intensity of fluorescence from the tumor was stronger than that from surrounding normal tissues. Histochemical examination confirmed that the tumor was located inside the gallbladder and adjacent liver parenchyma of mice. Conclusions: Our study showed that a fluorescent IGF-1R-targeted antibody could help detect gallbladder tumors. Tumor-specific imaging technology can be applied to endoscopy, laparoscopy, and robotic surgery for better management of gallbladder cancer.
Abstract
Background/Aims: Gallbladder cancer is fatal, but fluorescent imaging technology can facilitate timely diagnosis and improve patient outcomes. Fluorophore-conjugated insulin-like growth factor- 1 receptor (IGF-1R) targeted antibodies were used to visualize gallbladder cancer in orthotopic tumor mouse models. Methods: Western blotting, flow cytometric analysis, and confocal microscopy detected the expression of IGF-1R in SNU-308, SNU-478, and SNU-1196 bile duct cancer cells. In vivo imaging of SNU-478 and SNU-1196 subcutaneous tumors and orthotopic gallbladder tumor models of SNU-478 were performed after injection with DyLight 650-conjugated IGF-1R antibody. Results: Western blotting and flow cytometric analysis showed that IGF-1R was expressed in bile duct cancer cells, and confocal microscopy demonstrated that IGF-1R antibody was able to bind to IGF-1R on the cell membrane. Fluorescent IGF-1R antibody injected into the mouse tail vein made subcutaneous tumors and orthotopic tumors become fluorescent. The intensity of fluorescence from the tumor was stronger than that from surrounding normal tissues. Histochemical examination confirmed that the tumor was located inside the gallbladder and adjacent liver parenchyma of mice. Conclusions: Our study showed that a fluorescent IGF-1R-targeted antibody could help detect gallbladder tumors. Tumor-specific imaging technology can be applied to endoscopy, laparoscopy, and robotic surgery for better management of gallbladder cancer.
참고문헌 (24)
- Rawla P, "Epidemiology of gallbladder cancer", Clin Exp Hepatol, 5, pp.93~102 (2019)
- Hickman L, "Gallbladder cancer : diagnosis, surgical management, and adjuvant therapies", Surg Clin North Am, 99, pp.337~355 (2019)
- Kellil T, "Incidence and preoperative predictor factors of gallbladder cancer before laparoscopic cholecystectomy : a systematic review", J Gastrointest Cancer, 52, pp.68~72 (2021)
- Hiroshima Y, "Successful fluorescence-guided surgery on human colon cancer patientderived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system", J Laparoendosc Adv Surg Tech A, 24, pp.241~247 (2014)
- Park JY, "Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models", Oncotarget, 7, pp.18262~18268 (2016)
- Park JY, "Fluorescent-antibody targeting of insulin-like growth factor-1 receptor visualizes metastatic human colon cancer in orthotopic mouse models", PLoS One, 11, pp.e0146504~ (2016)
- Hernot S, "Latest developments in molecular tracers for fluorescence image-guided cancer surgery", Lancet Oncol, 20, pp.e354~e367 (2019)
- Metildi CA, "Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen(CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer", Ann Surg Oncol, 21, pp.1405~1411 (2014)
- Pollak MN, "Insulin-like growth factors and neoplasia", Nat Rev Cancer, 4, pp.505~518 (2004)
- Maloney EK, "An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation", Cancer Res, 63, pp.5073~5083 (2003)
- Heskamp S, "Optimization of IGF-1R SPECT", CT imaging using 111In-labeled F(ab')2 and Fab fragments of the monoclonal antibody R1507, 2012, pp.9, 2314~2321
- Zhang H, "Fluorescent tumour imaging of type I IGF receptor in vivo : comparison of antibody-conjugated quantum dots and small-molecule fluorophore", Br J Cancer, 101, pp.71~79 (2009)
- Vaquero J, "The IGF2", IR, Clin Cancer Res, pp.2018, 24[DOI]
- Suzuki H, "Expression of insulinlike growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients", Mol Clin Oncol, 3, pp.464~470 (2015)
- Xu L, "Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines", BMC Cancer, 10, pp.302~ (2010)
- Kornprat P, "Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma : a systematic analysis including primary and corresponding metastatic tumours", J Clin Pathol, 59, pp.202~206 (2006)
- Maawy AA, "Comparison of a chimeric anti-carcinoembryonic antigen antibody conjugated with visible or near-infrared fluorescent dyes for imaging pancreatic cancer in orthotopic nude mouse models", J Biomed Opt, 18, pp.126016~ (2013)
- Ahmad A, "Use of indocyanine green(ICG)augmented nearinfrared fluorescence imaging in robotic radical resection of gallbladder adenocarcinomas", Surg Endosc, 34, pp.2490~2494 (2020)
- Egberts JH, "Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma", Clin Exp Metastasis, 24, pp.141~148 (2007)
- Horiuchi H, "A MEK inhibitor(U0126)markedly inhibits direct liver invasion of orthotopically inoculated human gallbladder cancer cells in nude mice", J Exp Clin Cancer Res, 23, pp.599~606 (2004)
- Mita Y, "Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice", Ann Surg Oncol, 14, pp.1374~1380 (2007)
- Lee NP, "Tumor xenograft animal models for esophageal squamous cell carcinoma", J Biomed Sci, 25, pp.66~ (2018)
- Cornelissen B, "The level of insulin growth factor-1 receptor expression is directly correlated with the tumor uptake of(111)In-IGF-1(E3R)in vivo and the clonogenic survival of breast cancer cells exposed in vitro to trastuzumab(Herceptin)", Nucl Med Biol, 35, pp.645~653 (2008)
- Su X, "PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule", Amino Acids, 47, pp.1409~1419 (2015)